TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
ABVX

Abivax S.A.

Healthcare · Biotechnology

105.00$ -1.8% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow ABVX
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
+177.6% -125.7% -23.7% +12.7% -17.5% +357.6% +60.6% +45.8% +55.6% -6.4%
-240.6% +147.3% +75.0%
+95.3% -24.3% +116.7% -14.4% +48.8% +37.9% -106.9% -93.3% +146.5%
+2,273.5% -29.7% +35.8% -22.1% +23.3% -4.6% -94.8% +587.2% -18.0% +142.6% -78.8%
+2,262.8% -90.7% +11.7% +141.9% +45.7% +55.4% +983.8% +93.0% -12.7% -183.6%
+115.0% -18.7% -151.2% +146.0% -258.8%
+777.3% -100.8% +316.6% +127.3% +102.9% +65.6% -61.0% +957.3% -91.7% +1,785.8%
+1,156.7% -144.6% +60.8% -207.5% -147.9%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?